These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17525716)

  • 1. Hypothesis--haptoglobin genotype and diabetic nephropathy.
    Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
    Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
    Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.
    Levy AP
    Pharmacol Ther; 2006 Nov; 112(2):501-12. PubMed ID: 16854468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.
    Miller-Lotan R; Herskowitz Y; Kalet-Litman S; Nakhoul F; Aronson D; Zoabi R; Asaf R; Ben-Izhak O; Sabo E; Lim SK; Baumann H; Berger FG; Levy AP
    Diabetes Metab Res Rev; 2005; 21(4):332-7. PubMed ID: 15852445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
    Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
    Asleh R; Levy AP
    Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin genotype determines myocardial infarct size in diabetic mice.
    Blum S; Asaf R; Guetta J; Miller-Lotan R; Asleh R; Kremer R; Levy NS; Berger FG; Aronson D; Fu X; Zhang R; Hazen SL; Levy AP
    J Am Coll Cardiol; 2007 Jan; 49(1):82-7. PubMed ID: 17207726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin polymorphism and diabetic retinopathy in Brazilian patients.
    Wobeto VP; Rosim ET; Melo MB; Calliari LE; Sonati Mde F
    Diabetes Res Clin Pract; 2007 Sep; 77(3):385-8. PubMed ID: 17275123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HAPTOGLOBIN POLYMORPHISM AS AN INDEPENDENT PREDICTOR OF DIABETIC NEPHROPATHY AND RETINOPATHY].
    Dahan I; Thauho N; Nakhoul F; Nakhoul N; Jabaly H; Farber E
    Harefuah; 2016 Jul; 155(7):439-442. PubMed ID: 28514126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
    Asleh R; Marsh S; Shilkrut M; Binah O; Guetta J; Lejbkowicz F; Enav B; Shehadeh N; Kanter Y; Lache O; Cohen O; Levy NS; Levy AP
    Circ Res; 2003 Jun; 92(11):1193-200. PubMed ID: 12750308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?
    Ratzmann KP; Strese J; Keilacker H; Giebelmann R; Scheibe F; Witt S
    Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
    Dalan R; Liuh Ling G
    Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
    N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.
    Shor M; Boaz M; Gavish D; Wainshtein J; Matas Z; Shargorodsky M
    Am J Cardiol; 2007 Dec; 100(12):1767-70. PubMed ID: 18082523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
    Costacou T; Orchard TJ
    J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes?
    Goldenberg-Cohen N; Gabbay M; Dratviman-Storobinsky O; Reich E; Axer-Siegel R; Weinberger D; Gabbay U
    Retina; 2011 Sep; 31(8):1574-80. PubMed ID: 21555971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque.
    Levy AP; Levy JE; Kalet-Litman S; Miller-Lotan R; Levy NS; Asaf R; Guetta J; Yang C; Purushothaman KR; Fuster V; Moreno PR
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):134-40. PubMed ID: 17068284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus.
    Miller-Lotan R; Miller B; Nakhoul F; Aronson D; Asaf R; Levy AP
    Diabetes Metab Res Rev; 2007 Feb; 23(2):152-6. PubMed ID: 16742000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis.
    Purushothaman M; Krishnan P; Purushothaman KR; Baber U; Tarricone A; Perez JS; Wiley J; Kini A; Sharma SK; Fuster V; Moreno PR
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2769-75. PubMed ID: 22982461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.